Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Journal of Diabetes Research
|
May 15, 2013
Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ
Edward H Leiter, Marjorie Strobel, Adam O'Neill, et al.
Cancer Cell International
|
November 30, 2007
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids
Aaron L Miller, Spogmai Komak, M Scott Webb, et al.
Vascular Pharmacology
|
June 6, 2006
Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism
Huei-Ju Pan, Yiming Lin, Yuqing E Chen, et al.
Diabetes
|
April 28, 2005
Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex
Darcy P Pomerleau, Rebecca J Bagley, David V Serreze, et al.
Free Radical Biology & Medicine
|
April 9, 2002
Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice
Clayton E Mathews, Brian D Dunn, Michael O Hannigan, et al.
Novartis Foundation Symposium
|
February 11, 2009
Bone marrow expressing a diabetes resistance MHC class II allele: diabetes deviation by chronic immune stimulation
Peter Reifsnyder, William Schott, Darcy Pomerleau, et al.
Journal of Lipid Research
|
October 29, 2002
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone
Steven M Watkins, Peter R Reifsnyder, Huei-ju Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 5, 2006
Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production
Shinjiro Hamano, Amon Asgharpour, Suzanne E Stroup, et al.
Endocrinology
|
October 29, 2005
Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes
Edward H Leiter, Peter C Reifsnyder, Weidong Zhang, et al.
Free Radical Biology & Medicine
|
August 23, 2008
Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes
Jing Chen, Ying Lu, Chul-Ho Lee, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Journal of Diabetes Research
|
May 15, 2013
Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ
Edward H Leiter, Marjorie Strobel, Adam O'Neill, et al.
Cancer Cell International
|
November 30, 2007
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids
Aaron L Miller, Spogmai Komak, M Scott Webb, et al.
Vascular Pharmacology
|
June 6, 2006
Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism
Huei-Ju Pan, Yiming Lin, Yuqing E Chen, et al.
Diabetes
|
April 28, 2005
Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex
Darcy P Pomerleau, Rebecca J Bagley, David V Serreze, et al.
Free Radical Biology & Medicine
|
April 9, 2002
Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice
Clayton E Mathews, Brian D Dunn, Michael O Hannigan, et al.
Novartis Foundation Symposium
|
February 11, 2009
Bone marrow expressing a diabetes resistance MHC class II allele: diabetes deviation by chronic immune stimulation
Peter Reifsnyder, William Schott, Darcy Pomerleau, et al.
Journal of Lipid Research
|
October 29, 2002
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone
Steven M Watkins, Peter R Reifsnyder, Huei-ju Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 5, 2006
Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production
Shinjiro Hamano, Amon Asgharpour, Suzanne E Stroup, et al.
Endocrinology
|
October 29, 2005
Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes
Edward H Leiter, Peter C Reifsnyder, Weidong Zhang, et al.
Free Radical Biology & Medicine
|
August 23, 2008
Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes
Jing Chen, Ying Lu, Chul-Ho Lee, et al.
Page
of 6